Genetic and transcriptional evolution alters cancer cell line drug responseUri Ben‐David, Todd R. Golub, Nicholas Lyons et al.|Nature|2018Cited by 943
Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibitionYael Cohen‐Sharir, Uri Ben‐David, James M. McFarland et al.|Nature|2021Cited by 302
Pharmacokinetic and Pharmacodynamic Equivalence of Pegfilgrastim-cbqv and Pegfilgrastim in Healthy SubjectsBarbara Finck, Vladimir Vexler, Helen Tang et al.|Advances in Therapy|2020Cited by 18
Biochemical evidence that the whole compartment activity behavior of GAPDH differs between the cytoplasm and nucleusHelen Tang, Michael C. Schultz|PLoS ONE|2023Cited by 6